| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MARCO | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | RTN4 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PTPN9 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | ACKR1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | ASCL4 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | CFAP57 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | CDC42 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | OR8H1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | MFSD2B | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | UBXN8 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
